Concepedia

Yvonne Nilsson

YN

Statistics

Publications

5

Citations

1.6K

H-Index

5

Active since

1998

Affiliations

AstraZeneca (Sweden)(Current)

Yvonne Nilsson is an author at AstraZeneca (Sweden) specializing in medicine, cell signaling, and cell biology.

Top concepts

Publications per year

1998–2013

5

Publications

5

Differential Response of Estrogen Receptor α and Estrogen Receptor β to Partial Estrogen Agonists/Antagonists

Tomas Barkhem, Bo Carlsson, Yvonne Nilsson et al. · Molecular Pharmacology · 1998 · 772 citations

Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-specific Inhibitor AR-A014418

Ratan V. Bhat, Yafeng Xue, Stefan von Berg et al. · Journal of Biological Chemistry · 2003 · 538 citations · Full text

Discovery of Novel Potent and Highly Selective Glycogen Synthase Kinase-3β (GSK3β) Inhibitors for Alzheimer’s Disease: Design, Synthesis, and Characterization of Pyrazines

Stefan von Berg, Margareta Bergh, Sven Hellberg et al. · Journal of Medicinal Chemistry · 2012 · 145 citations · Full text

<scp>AZD</scp>1080, a novel <scp>GSK</scp>3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans

Biljana Georgievska, Johan Sandin, James Doherty et al. · Journal of Neurochemistry · 2013 · 116 citations · Full text

, , +26

GSK-3 inhibition by an orally active small molecule increases bone mass in rats

Richard Marsell, Gregor Sisask, Yvonne Nilsson et al. · Bone · 2011 · 68 citations

, , +11

1–5 of 5